Lifevantage Corporation (LFVN)
| Previous close | 6.11 |
| Open | 6.06 |
| Bid | 0.00 x 0 |
| Ask | 6.45 x 100 |
| Day's range | 6.06 - 6.57 |
| 52-week range | 3.10 - 8.69 |
| Volume | |
| Avg. volume | 35,885 |
| Market cap | 84.546M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 27.38 |
| EPS (TTM) | 0.24 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 0.14 (2.30%) |
| Ex-dividend date | 29 Feb 2024 |
| 1y target est | N/A |
- GuruFocus.com
Lifevantage Corp (LFVN) (Q3 2024) Earnings Call Transcript Highlights: Mixed Results Amidst ...
Despite a downturn in revenue and gross margins, LFVN reports robust growth in adjusted EBITDA and strategic enhancements in product offerings and market initiatives.
GlobeNewswireLifeVantage Declares Quarterly Dividend
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid June 14, 2024 to all stockholders of record at the close of business on May 31, 2024. This represents an increase in the dividend amount by 14.
- GlobeNewswire
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2024
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2024. Third Quarter Fiscal 2024 Summary*: Revenue of $48.2 million, a decrease of 10.2% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue was down a
